Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen, Biobase, University of Washington Microarray Analysis Workshops, Summer School for Biological Modeling, AstraZeneca

Premium

Invitrogen Licenses GeneGo’s Pathway Tools

GeneGo said last week that Invitrogen has signed a multi-year license for its pathway analysis platform.

GeneGo said the companies plan to “work closely together to develop new capabilities” under the agreement, but did not provide further details.


BASF to Use Biobase’s Brenda Database

Biobase said last week that BASF Plant Science has licensed its Brenda enzyme database for use in its plant biotechnology research programs.

Financial terms of the licensing agreement were not disclosed.

The Brenda database contains information on 83,000 different enzymes from 9,800 organisms and additional metabolic data that has been manually annotated from more than 46,000 publications, Biobase said.


U Wash Holds Microarray Analysis Workshops

The BioArray Center at the University of Washington said it will host two microarray analysis workshops this summer entitled, “High-Powered Microarray Analysis Using Low/No-Cost Tools.”

The workshops will focus on freely available tools to analyze microarray data. The first, geared toward single-color analysis, will be held June 21-22; and the second, on two-color analysis, will be held July 13-14.

Further information is available at http://ra.microslu.washington.edu/workshop/ArrayWorkshopJuly03.htm.


Summer School for Biological Modeling

Germany’s International University of Bremen will host a summer course, “Advanced Modeling of Biological Function,” August 7-13.

The course will address the use of computational methods to model biological data, including biological structures and selected interactions as well as complex biological networks.

Further details are available at http://www.iu-bremen.de/ses/bicb/summerschool2004.


AstraZeneca to Collaborate with Iconix

Iconix said last week that it will apply its DrugMatrix chemogenomic profiling database in a cancer drug discovery collaboration with AstraZeneca.

AstraZeneca will use the platform to study mechanisms of toxicity and to identify genomic biomarkers that can be used as counterscreens in short-term studies.

 

Filed under

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.